Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention

Z. Al-Kadhimi, Z. Gul, M. Abidi, L. G. Lum, A. Deol, W. Chen, H. Jang, C. Ozust, A. Langston, E. Waller, J. Uberti

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention'. Together they form a unique fingerprint.

Medicine & Life Sciences